Literature DB >> 18535293

Effects of extracellular matrixes and growth factors on the hepatic differentiation of human embryonic stem cells.

Takamichi Ishii1, Ken Fukumitsu, Kentaro Yasuchika, Keiko Adachi, Eihachiro Kawase, Hirofumi Suemori, Norio Nakatsuji, Iwao Ikai, Shinji Uemoto.   

Abstract

Hepatocytes derived from human embryonic stem cells (hESCs) are a potential cell source for regenerative medicine. However, the definitive factors that are responsible for hepatic differentiation of hESCs remain unclear. We aimed to evaluate the effects of various extracellular matrixes and growth factors on endodermal differentiation and to optimize the culture conditions to induce hepatic differentiation of hESCs. The transgene vector that contained enhanced green fluorescent protein (EGFP) under the control of human alpha-fetoprotein (AFP) enhancer/promoter was transfected into hESC lines. The transgenic hESCs were cultured on extracellular matrixes (collagen type I, laminin, and Matrigel) in the presence or absence of growth factors including hepatocyte growth factor (HGF), bone morphogenetic protein 4, fibroblast growth factor 4, all-trans-retinoic acid, and activin A. The expression of AFP-EGFP was measured by flow cytometry. The culture on Matrigel-coated dishes with 100 ng/ml activin A showed 19.5% of EGFP-positive proportions. Moreover, the sequential addition of 100 ng/ml activin A and 20 ng/ml HGF resulted in 21.7% and produced a higher yield of EGFP-positive cells than the group stimulated by activin A alone. RT-PCR and immunocytochemical staining revealed these EGFP-positive cells to differentiate into mesendoderm-like cells by use of activin A and then into hepatic endoderm cells by use of HGF. Two other hESC lines also differentiated into endoderm on the hepatic lineage by our method. In conclusion, we therefore found this protocol to effectively differentiate multiple hESC lines to early hepatocytes using activin A and HGF on Matrigel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535293     DOI: 10.1152/ajpgi.00072.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  27 in total

1.  Quantitative and semiquantitative immunoassay of growth factors and cytokines in the conditioned medium of STO and CF-1 mouse feeder cells.

Authors:  Neil C Talbot; Wendy O Sparks; Anne M Powell; Stanislaw Kahl; Thomas J Caperna
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-12-17       Impact factor: 2.416

2.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

Review 3.  Substrates for clinical applicability of stem cells.

Authors:  Sanjar Enam; Sha Jin
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

4.  Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines.

Authors:  Akemi Takata; Motoyuki Otsuka; Tomomi Kogiso; Kentaro Kojima; Takeshi Yoshikawa; Ryosuke Tateishi; Naoya Kato; Shuichiro Shiina; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
Journal:  Hepatol Int       Date:  2011-02-06       Impact factor: 6.047

5.  Cell differentiation mediated by co-culture of human umbilical cord blood stem cells with murine hepatic cells.

Authors:  Maria Stecklum; Annika Wulf-Goldenberg; Bettina Purfürst; Antje Siegert; Marlen Keil; Klaus Eckert; Iduna Fichtner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-10-01       Impact factor: 2.416

Review 6.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

Review 7.  Application of whole-organ tissue engineering in hepatology.

Authors:  Basak E Uygun; Martin L Yarmush; Korkut Uygun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-14       Impact factor: 46.802

Review 8.  Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Authors:  Ann Peters; Paul W Burridge; Marina V Pryzhkova; Michal A Levine; Tea-Soon Park; Christopher Roxbury; Xuan Yuan; Bruno Péault; Elias T Zambidis
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

9.  Differentiation of human embryonic stem cells to hepatocyte-like cells on a new developed xeno-free extracellular matrix.

Authors:  Zahra Farzaneh; Mohammad Pakzad; Massoud Vosough; Behshad Pournasr; Hossein Baharvand
Journal:  Histochem Cell Biol       Date:  2014-01-30       Impact factor: 4.304

Review 10.  Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction.

Authors:  Ruchi Sharma; Sebastian Greenhough; Claire N Medine; David C Hay
Journal:  J Biomed Biotechnol       Date:  2010-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.